Kröger, N <br/><br/>
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.  [electronic resource] 

 -  Leukemia  Oct 2011 
 - 1657-61 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2011.138  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Disease Progression<br/>Female<br/>Haplotypes<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--surgery<br/>Receptors, KIR--genetics<br/>Survival Analysis<br/>Transplantation, Homologous